4//SEC Filing
Warma Neil K 4
Accession 0001140361-13-018273
CIK 0001069308other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 9:10 PM ET
Size
10.0 KB
Accession
0001140361-13-018273
Insider Transaction Report
Form 4
Warma Neil K
President & CEO
Transactions
- Award
Employee Stock Option (right to buy)
2013-02-04+95,970→ 95,970 totalExercise: $3.80Exp: 2022-01-06→ Common Stock (95,970 underlying) - Award
Employee Stock Option (right to buy)
2013-04-29+50,000→ 50,000 totalExercise: $1.75Exp: 2023-04-29→ Common Stock (50,000 underlying) - Award
Common Stock
2013-04-29+28,571→ 37,229 total
Footnotes (3)
- [F1]On January 6, 2012, the reporting person was granted an option to purchase 139,593 shares of common stock at the closing market price. The option is performance based and begins to vest quarterly over a three-year period in two tranches commencing upon Opexa achieving certain key milestones. The second tranche key milestone for vesting of 95,970 shares is Opexa entering into a collaboration, partnership or other strategic arrangement involving US rights for Tcelna. The performance criteria for the second key milestone was met on February 4, 2013 and vesting has commenced for the second tranche of 95,970 shares.
- [F2]All share numbers and the exercise price have been adjusted to reflect the one-for-four reverse stock split implemented December 14, 2012.
- [F3]Quarterly vesting on the anniversary date of the grant over three years.
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeother
Related Parties
1- filerCIK 0001437911
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 9:10 PM ET
- Size
- 10.0 KB